CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 135 filers reported holding CRISPR THERAPEUTICS AG in Q1 2018. The put-call ratio across all filers is 3.59 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,796 | +95.7% | 1,035 | +137.9% | 0.00% | – |
| Q2 2023 | $24,421 | -15.0% | 435 | -31.5% | 0.00% | – |
| Q1 2023 | $28,721 | +11.3% | 635 | 0.0% | 0.00% | – |
| Q4 2022 | $25,813 | -37.0% | 635 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $41,000 | +5.1% | 635 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | +160.0% | 635 | +159.2% | 0.00% | – |
| Q1 2022 | $15,000 | -21.1% | 245 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | +280.0% | 245 | +444.4% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 45 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | – | 45 | +800.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 5 | -99.2% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 600 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -22.9% | 600 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $35,000 | +29.6% | 600 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | +92.9% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 600 | 0.0% | 0.00% | – |
| Q3 2017 | $11,000 | +10.0% | 600 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 600 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | +8.3% | 600 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |